Company Filing History:
Years Active: 2011-2015
Title: The Innovations of Patrick D. Elias
Introduction
Patrick D. Elias is a notable inventor based in Pullman, WA (US). He has made significant contributions to the field of medical research, particularly in understanding and treating conditions associated with c-Met dysregulation. With a total of 3 patents, his work has the potential to impact various health conditions, including cancer and neurodegenerative diseases.
Latest Patents
One of Patrick D. Elias's latest patents focuses on C-Met receptor regulation by angiotensin IV (AT4) receptor ligands. This patent provides compositions and methods for diagnosing, preventing, and treating conditions associated with c-Met dysregulation. The conditions addressed include cancer, obesity, and neurodegenerative diseases such as general dementia, Alzheimer's disease, Parkinson's disease, Amyotrophic Lateral Sclerosis, traumatic brain injury, and spinal cord trauma. His research identifies the cell surface c-Met receptor as the Angiotensin-IV receptor (AT(4)R), which plays a crucial role in processes like HGF-regulated cell motility, angiogenesis, and cancer metastasis.
Career Highlights
Patrick D. Elias is affiliated with Washington State University, where he continues to advance his research and innovations. His work is characterized by a commitment to understanding complex biological processes and developing therapeutic strategies that can improve patient outcomes.
Collaborations
Some of his notable coworkers include Joseph W. Harding and John W. Wright. Their collaborative efforts contribute to the advancement of research in the field of medical science.
Conclusion
Patrick D. Elias exemplifies the spirit of innovation in the medical research community. His patents and ongoing work hold promise for addressing significant health challenges, making him a key figure in the field.